185 related articles for article (PubMed ID: 3093104)
41. B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.
O'Garra A; Rigley KP; Holman M; McLaughlin JB; Klaus GG
Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6254-8. PubMed ID: 3498163
[TBL] [Abstract][Full Text] [Related]
42. Inhibitory effect of the alkaloid warifteine purified from Cissampelos sympodialis on B lymphocyte function in vitro and in vivo.
Rocha JD; Decoté-Ricardo D; Redner P; Lopes UG; Barbosa-Filho JM; Piuvezam MR; Arruda LB; Maria Torres Peçanha L
Planta Med; 2010 Mar; 76(4):325-30. PubMed ID: 19787569
[TBL] [Abstract][Full Text] [Related]
43. Tumor-promoting phorbol esters suppress receptor-stimulated inositol phospholipid degradation and Ca2+ mobilization in mouse lymphocytes.
Bijsterbosch MK; Klaus GG
Eur J Immunol; 1987 Jan; 17(1):113-8. PubMed ID: 3028820
[TBL] [Abstract][Full Text] [Related]
44. Properties of anti-Lyb-2-mediated B-cell activation and the relationship between Lyb-2 molecules and receptors for B-cell stimulatory factor-1 on murine B lymphocytes.
Subbarao B; Morris J; Baluyut AR
Cell Immunol; 1988 Apr; 112(2):329-42. PubMed ID: 3281760
[TBL] [Abstract][Full Text] [Related]
45. Response of human B cells to different anti-immunoglobulin isotypes: absence of a correlation between early activation events and cell proliferation.
Roifman CM; Mills GB; Stewart D; Cheung RK; Grinstein S; Gelfand EW
Eur J Immunol; 1987 Dec; 17(12):1737-42. PubMed ID: 3500860
[TBL] [Abstract][Full Text] [Related]
46. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
47. The reactivity of frozen B lymphocytes to B cell mitogens and human B cell growth factor: a study of step 1 and step 2 activators.
Bertoglio JH; Appel BS
Cell Immunol; 1985 Jan; 90(1):32-40. PubMed ID: 3871363
[TBL] [Abstract][Full Text] [Related]
48. Requirements of a costimulus for IL-4-induced IgE class switching in murine B cells activated via antigen receptors: effectiveness of 8-mercaptoguanosine.
Hikida M; Takai T; Ohmori H
J Immunol; 1996 Apr; 156(8):2730-6. PubMed ID: 8609390
[TBL] [Abstract][Full Text] [Related]
49. Identification of two distinct factors, B151-TRF1 and B151-TRF2, inducing differentiation of activated B cells and small resting B cells into antibody-producing cells.
Ono S; Hayashi S; Takahama Y; Dobashi K; Katoh Y; Nakanishi K; Paul WE; Hamaoka T
J Immunol; 1986 Jul; 137(1):187-96. PubMed ID: 3519774
[TBL] [Abstract][Full Text] [Related]
50. A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1).
Mishra GC; Berton MT; Oliver KG; Krammer PH; Uhr JW; Vitetta ES
J Immunol; 1986 Sep; 137(5):1590-8. PubMed ID: 3091687
[TBL] [Abstract][Full Text] [Related]
51. A role for Lyb-2 in B cell activation mediated by a B cell stimulatory factor.
Yakura H; Kawabata I; Ashida T; Shen FW; Katagiri M
J Immunol; 1986 Sep; 137(5):1475-81. PubMed ID: 3091682
[TBL] [Abstract][Full Text] [Related]
52. Isotype switching in anti-immunoglobulin-activated B lymphoblasts: differential requirements for interleukin 4 and other lymphokines to elicit membrane vs. secreted IgG1.
Purkerson JM; Isakson PC
Eur J Immunol; 1991 Mar; 21(3):707-14. PubMed ID: 2009912
[TBL] [Abstract][Full Text] [Related]
53. Human interferon-gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity.
Defrance T; Aubry JP; Vanbervliet B; Banchereau J
J Immunol; 1986 Dec; 137(12):3861-7. PubMed ID: 3097134
[TBL] [Abstract][Full Text] [Related]
54. Induction of antigen-specific proliferation in affinity-purified small B lymphocytes: requirement for BSF-1 by type 2 but not type 1 thymus-independent antigens.
Stein P; Dubois P; Greenblatt D; Howard M
J Immunol; 1986 Mar; 136(6):2080-9. PubMed ID: 3081637
[TBL] [Abstract][Full Text] [Related]
55. Requirement for BSF-1 in the induction of antigen-specific B cell proliferation by a thymus-dependent antigen and carrier-reactive T cell line.
Dubois P; Stein P; Ennist D; Greenblatt D; Mosmann T; Howard M
J Immunol; 1987 Sep; 139(6):1927-34. PubMed ID: 2957442
[TBL] [Abstract][Full Text] [Related]
56. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
[TBL] [Abstract][Full Text] [Related]
57. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.
Coffman RL; Ohara J; Bond MW; Carty J; Zlotnik A; Paul WE
J Immunol; 1986 Jun; 136(12):4538-41. PubMed ID: 3486902
[TBL] [Abstract][Full Text] [Related]
58. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
[TBL] [Abstract][Full Text] [Related]
59. Activation and proliferation signals in mouse B cells. VII. Calcium ionophores are non-mitogenic polyclonal B-cell activators.
Klaus GG; Bijsterbosch MK; Holman M
Immunology; 1985 Oct; 56(2):321-7. PubMed ID: 2414214
[TBL] [Abstract][Full Text] [Related]
60. Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells.
Mittler RS; Greenfield RS; Schacter BZ; Richard NF; Hoffmann MK
J Immunol; 1987 May; 138(10):3159-66. PubMed ID: 2952710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
